152 related articles for article (PubMed ID: 14748874)
1. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.
Arvanitidis D; Anagnostopoulos GK; Giannopoulos D; Pantes A; Agaritsi R; Margantinis G; Tsiakos S; Sakorafas G; Kostopoulos P
J Gastroenterol Hepatol; 2004 Mar; 19(3):278-82. PubMed ID: 14748874
[TBL] [Abstract][Full Text] [Related]
2. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
[TBL] [Abstract][Full Text] [Related]
3. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
4. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.
Bordas JM; Toledo-Pimentel V; Llach J; Elena M; Mondelo F; Ginès A; Terés J
Gastrointest Endosc; 1998 Mar; 47(3):230-4. PubMed ID: 9540874
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
[TBL] [Abstract][Full Text] [Related]
6. [Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, non-randomized study].
Vila JJ; Jiménez FJ; Prieto C; Borobio E; Juanmartiñena JF; Borda F
Gastroenterol Hepatol; 2006 Apr; 29(4):231-6. PubMed ID: 16584693
[TBL] [Abstract][Full Text] [Related]
7. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F
Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
[TBL] [Abstract][Full Text] [Related]
8. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
9. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST
Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
[TBL] [Abstract][Full Text] [Related]
12. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography.
Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM
J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324
[TBL] [Abstract][Full Text] [Related]
13. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
14. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
Tsujino T; Komatsu Y; Isayama H; Hirano K; Sasahira N; Yamamoto N; Toda N; Ito Y; Nakai Y; Tada M; Matsumura M; Yoshida H; Kawabe T; Shiratori Y; Omata M
Clin Gastroenterol Hepatol; 2005 Apr; 3(4):376-83. PubMed ID: 15822043
[TBL] [Abstract][Full Text] [Related]
15. Can somatostatin prevent injection pancreatitis after ERCP?
Persson B; Slezak P; Efendic S; Häggmark A
Hepatogastroenterology; 1992 Jun; 39(3):259-61. PubMed ID: 1380475
[TBL] [Abstract][Full Text] [Related]
16. [Meta-analysis: somatostatin for prophylaxis against post endoscopic retrograde cholangiopancreatography pancreatitis].
Pan SB; Geng XP
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):466-472. PubMed ID: 27938583
[No Abstract] [Full Text] [Related]
17. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
[TBL] [Abstract][Full Text] [Related]
18. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial.
Katsinelos P; Kountouras J; Chatzis J; Christodoulou K; Paroutoglou G; Mimidis K; Beltsis A; Zavos C
Gastrointest Endosc; 2005 Mar; 61(3):407-15. PubMed ID: 15758912
[TBL] [Abstract][Full Text] [Related]
19. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
[TBL] [Abstract][Full Text] [Related]
20. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
